Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Attinger

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 1, 2001
T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TLA J Leishman, O V Naidenko, A Attinger, et al.
Blood Cancer Journal|July 26, 2012
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplantsA Nahimana, D Aubry, L Lagopoulos, et al.
Immunological Reviews|July 10, 1999
Interplays between mouse mammary tumor virus and the cellular and humoral immune responseH Acha-Orbea, D Finke, A Attinger, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 1, 2001
T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TLA J Leishman, O V Naidenko, A Attinger, et al.
Blood Cancer Journal|July 26, 2012
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplantsA Nahimana, D Aubry, L Lagopoulos, et al.
Immunological Reviews|July 10, 1999
Interplays between mouse mammary tumor virus and the cellular and humoral immune responseH Acha-Orbea, D Finke, A Attinger, et al.
Pageof 2